INTRAVESICAL ADMINISTRATION OF EG110A, A NOVEL NON-REPLICATIVE HERPES SIMPLEX VIRUS TYPE 1 (HSV1)-DERIVED VECTOR EXPRESSING THE LIGHT CHAIN OF BOTULINUM TOXIN F, INHIBITS C-TYPE FIBERS IN AN ACUTE INTRAVESICAL CAPSAICIN RAT MODEL
Ratelade, J, Faugeroux, J, Behr-Roussel, D, Epstein, A, Denys, P, Giuliano, F, Haag-Molkenteller, C, Salot, S
Published in Continence (Amsterdam) (01.09.2023)
Published in Continence (Amsterdam) (01.09.2023)
Get full text
Journal Article
33 - EG110A, a novel non-replicative HSV1-derived vector expressing the light chain of botulinum toxin F, shows dose-dependent efficacy in an acute intravesical capsaicin rat model
Ratelade, J, Epstein, A, Denys, P, Giuliano, F, Haag-Molkenteller, C, Salot, S
Published in Continence (Amsterdam) (01.10.2024)
Published in Continence (Amsterdam) (01.10.2024)
Get full text
Journal Article
Large scale expansion of V gamma 9V delta 2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS ''TCR gamma / delta super(+) T cell isolation kit'
Salot, S, Bercegeay, S, Dreno, B, Saiagh, S, Scaglione, V, Bonnafous, C, Sicard, H
Published in Journal of immunological methods (15.08.2009)
Published in Journal of immunological methods (15.08.2009)
Get full text
Journal Article
Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product
Salot, Samuel, Laplace, Catherine, Saïagh, Soraya, Bercegeay, Sylvain, Tenaud, Isabelle, Cassidanius, Alain, Romagne, François, Dreno, Brigitte, Tiollier, Jérôme
Published in Journal of immunological methods (30.09.2007)
Published in Journal of immunological methods (30.09.2007)
Get full text
Journal Article
Vγ9Vδ2 T (γδ) lymphocytes: a promising approach for immunotherapy of solid tumors
Squiban, P. J., Bompas, E., Bennouna, J., Levy, V., Sicard, H., Lafaye de Micheaux, S., Viey, E., Salot, S., Tiollier, J., Calvo, F.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
An autologous Vγ9Vδ2 T lymphocytes cell therapy product generated by BrHPP (INNACELL Gamma Delta [IGD]) in metastatic renal cell carcinoma patients: Phase I clinical trial results
Bompas, E., Neidhardt, E. M., Rolland, F., Philip, I., Galéa, C., Salot, S., Tiollier, J., Saiagh, S., Negrier, S., Bennouna, J.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article